Primrose Bio presents and exhibits at Antibody Engineering & Therapeutics in San Diego, December 14-17, 2025.
• Diane Retallack, PhD presents a talk on Primrose Bio’s rapid, robust solution for accelerating antibody screening
P. fluorescens-based Pfenex Expression Technology® transforms protein production through combinatorial screening to identify robust strains. With >20 years of development and 6 marketed products, Pfenex excels where others fail. Launched in 2024, Pfast™ offers an affordable 10 day evaluation of protein titer and quality. Tested on >30 partner proteins, Pfast significantly improved productivity challenges, improving pipeline management with seamless integration.
• Chris Warner, PhD is presents a scientific poster on overcoming ncAA production bottlenecks for high-titer antibody expression
• We exhibit at Booth 305 – connect with Andrew Burch, Louis J. Cantolupo, and Alec Tzianabos
Learn more about our Pfenex Expression Technology platform for improved protein expression, including unmatched production of antibody fragments.
